638 related articles for article (PubMed ID: 34806762)
1. Renal denervation for resistant hypertension.
Pisano A; Iannone LF; Leo A; Russo E; Coppolino G; Bolignano D
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD011499. PubMed ID: 34806762
[TBL] [Abstract][Full Text] [Related]
2. Renal denervation for resistant hypertension.
Coppolino G; Pisano A; Rivoli L; Bolignano D
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011499. PubMed ID: 28220472
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Calcium supplementation for prevention of primary hypertension.
Cormick G; Ciapponi A; Cafferata ML; Cormick MS; Belizán JM
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD010037. PubMed ID: 35014026
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Saiz LC; Gorricho J; Garjón J; Celaya MC; Erviti J; Leache L
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010315. PubMed ID: 32905623
[TBL] [Abstract][Full Text] [Related]
6. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
[TBL] [Abstract][Full Text] [Related]
7. Calcium supplementation for prevention of primary hypertension.
Cormick G; Ciapponi A; Cafferata ML; Cormick MS; Belizán JM
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD010037. PubMed ID: 34693985
[TBL] [Abstract][Full Text] [Related]
8. Withdrawal of antihypertensive drugs in older people.
Reeve E; Jordan V; Thompson W; Sawan M; Todd A; Gammie TM; Hopper I; Hilmer SN; Gnjidic D
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012572. PubMed ID: 32519776
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
[TBL] [Abstract][Full Text] [Related]
10. Low dialysate sodium levels for chronic haemodialysis.
Dunlop JL; Vandal AC; Marshall MR
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011204. PubMed ID: 30646428
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for hypertension-induced left ventricular hypertrophy.
Leache L; Gutiérrez-Valencia M; Finizola RM; Infante E; Finizola B; Pardo Pardo J; Flores Y; Granero R; Arai KJ
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012039. PubMed ID: 34628642
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure targets in adults with hypertension.
Arguedas JA; Leiva V; Wright JM
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004349. PubMed ID: 33332584
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
Cooper TE; Teng C; Tunnicliffe DJ; Cashmore BA; Strippoli GF
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD007751. PubMed ID: 37466151
[TBL] [Abstract][Full Text] [Related]
15. Home versus in-centre haemodialysis for people with kidney failure.
Cheetham MS; Ethier I; Krishnasamy R; Cho Y; Palmer SC; Johnson DW; Craig JC; Stroumza P; Frantzen L; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD009535. PubMed ID: 38588450
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy for hypertension in adults aged 18 to 59 years.
Musini VM; Gueyffier F; Puil L; Salzwedel DM; Wright JM
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008276. PubMed ID: 28813123
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure targets for hypertension in older adults.
Garrison SR; Kolber MR; Korownyk CS; McCracken RK; Heran BS; Allan GM
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011575. PubMed ID: 28787537
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet agents and anticoagulants for hypertension.
Shantsila E; Kozieł-Siołkowska M; Lip GY
Cochrane Database Syst Rev; 2022 Jul; 7():CD003186. PubMed ID: 35900898
[TBL] [Abstract][Full Text] [Related]
19. Psychosocial interventions for preventing and treating depression in dialysis patients.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
[TBL] [Abstract][Full Text] [Related]
20. Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension.
Wang GM; Li LJ; Tang WL; Wright JM
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012569. PubMed ID: 33089502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
